Total Payments
$8,478
2024 Payments
$822.25
Companies
30
Transactions
314
Medicare Patients
10,822
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$8,233 (97.1%)
Other$150.00 (1.8%)
Education$94.66 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,233 | 312 | 97.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 1.8% |
| Education | $94.66 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,155 | 120 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,773 | 48 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $996.41 | 41 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $715.00 | 24 | $0 (2023) |
| Merz North America, Inc. | $414.36 | 2 | $0 (2019) |
| PFIZER INC. | $252.20 | 2 | $0 (2018) |
| Amgen Inc. | $242.36 | 6 | $0 (2024) |
| Lilly USA, LLC | $229.28 | 6 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $182.68 | 4 | $0 (2021) |
| Merck Sharp & Dohme LLC | $174.36 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $822.25 | 31 | GlaxoSmithKline, LLC. ($293.88) |
| 2023 | $1,292 | 43 | Regeneron Healthcare Solutions, Inc. ($636.42) |
| 2022 | $1,320 | 40 | Regeneron Healthcare Solutions, Inc. ($685.19) |
| 2021 | $704.33 | 29 | Regeneron Healthcare Solutions, Inc. ($190.37) |
| 2020 | $718.54 | 29 | Jazz Pharmaceuticals Inc. ($192.60) |
| 2019 | $1,089 | 37 | GlaxoSmithKline, LLC. ($242.71) |
| 2018 | $1,619 | 64 | GlaxoSmithKline, LLC. ($444.83) |
| 2017 | $912.33 | 41 | GlaxoSmithKline, LLC. ($378.19) |
All Payment Transactions
314 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| Category: Sleep | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Medical Device | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 08/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Respiratory | ||||||
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: RESPIRATORY | ||||||
| 04/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,145 | 7,549 | $2.3M | $468,653 |
| 2022 | 22 | 2,861 | 7,088 | $2.2M | $447,962 |
| 2021 | 22 | 2,408 | 7,216 | $2.2M | $443,850 |
| 2020 | 25 | 2,408 | 8,872 | $2.3M | $449,020 |
Total Patients
10,822
Total Services
30,725
Medicare Billing
$1.8M
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 618 | $185,400 | $65,118 | 35.1% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 193 | 379 | $189,500 | $40,990 | 21.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 210 | 757 | $227,100 | $38,898 | 17.1% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Office | 2023 | 207 | 848 | $169,600 | $37,470 | 22.1% |
| 95922 | Testing of autonomic (sympathetic) nervous system function, heart rate response to breathing exercises, and passive tilt | Office | 2023 | 194 | 382 | $191,000 | $32,809 | 17.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 51 | 55 | $154,000 | $32,168 | 20.9% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 195 | 396 | $198,000 | $30,009 | 15.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 49 | 50 | $140,000 | $27,073 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 340 | $68,000 | $26,011 | 38.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 184 | 472 | $141,600 | $23,244 | 16.4% |
| 94070 | Test to measure lung airway sensitivity | Office | 2023 | 192 | 366 | $73,000 | $19,589 | 26.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 200 | 416 | $124,800 | $16,480 | 13.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 173 | 602 | $68,900 | $14,875 | 21.6% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 205 | 804 | $201,000 | $14,070 | 7.0% |
| 94644 | Inhalation treatment for acute airway obstruction, first hour | Office | 2023 | 129 | 220 | $33,000 | $12,105 | 36.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 84 | 87 | $34,800 | $11,810 | 33.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 53 | 53 | $31,800 | $9,158 | 28.8% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 99 | 158 | $31,600 | $5,451 | 17.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 133 | 136 | $6,800 | $3,692 | 54.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 85 | 115 | $17,250 | $3,373 | 19.6% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 95 | 116 | $23,200 | $2,761 | 11.9% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 105 | 179 | $17,900 | $1,500 | 8.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 527 | $158,100 | $56,469 | 35.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 182 | 730 | $219,000 | $39,372 | 18.0% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Office | 2022 | 186 | 866 | $173,200 | $35,125 | 20.3% |
About Dr. John Saito, MD
Dr. John Saito, MD is a Pulmonary Disease healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851352678.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Saito, MD has received a total of $8,478 in payments from pharmaceutical and medical device companies, with $822.25 received in 2024. These payments were reported across 314 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($8,233).
As a Medicare-enrolled provider, Saito has provided services to 10,822 Medicare beneficiaries, totaling 30,725 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location Fountain Valley, CA
- Active Since 03/31/2006
- Last Updated 09/12/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851352678
Products in Payments
- DUPIXENT (Biological) $1,866
- TRELEGY ELLIPTA (Drug) $745.35
- NUCALA (Biological) $529.56
- BREO (Drug) $459.43
- XEOMIN (Biological) $414.36
- FASENRA (Drug) $370.38
- XYWAV (Drug) $331.92
- SYMBICORT (Drug) $300.70
- ANORO (Drug) $293.76
- EUCRISA (Drug) $252.20
- TALTZ (Drug) $229.28
- SUNOSI (Drug) $214.41
- TEZSPIRE (Biological) $205.62
- XYREM (Drug) $168.67
- QVAR (Drug) $166.13
- SPIRIVA RESPIMAT (Drug) $124.07
- LifeVest (Device) $120.23
- Enbrel (Biological) $112.29
- BELSOMRA (Drug) $95.65
- BOTOX COSMETIC (Biological) $76.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Fountain Valley
Dr. Hoang Le, M.d, M.D
Pulmonary Disease — Payments: $871,726
Pulmonary Disease $871,726
Dr. Viney Soni, M.d, M.D
Pulmonary Disease — Payments: $16,283
Pulmonary Disease $16,283
Malaygiri Aparnath, Md, MD
Pulmonary Disease — Payments: $14,395
Pulmonary Disease $14,395
Thomas Asciuto
Pulmonary Disease — Payments: $8,786
Pulmonary Disease $8,786
Dr. Abhishek Bhardwaj, M.d, M.D
Pulmonary Disease — Payments: $4,044
Pulmonary Disease $4,044
Dr. Prakash Bondade, M.d, M.D
Pulmonary Disease — Payments: $3,893
Pulmonary Disease $3,893